---
input_text: "Lovo-cel gene therapy for sickle cell disease: Treatment process evolution
  and outcomes in the initial groups of the HGB-206 study. lovo-cel (bb1111; LentiGlobin
  for sickle cell disease [SCD]) gene therapy (GT) comprises autologous transplantation
  of hematopoietic stem and progenitor cells transduced with the BB305 lentiviral
  vector encoding a modified beta-globin gene (betaA-T87Q ) to produce anti-sickling
  hemoglobin (HbAT87Q ). The efficacy and safety of lovo-cel for SCD are being evaluated
  in the ongoing phase 1/2 HGB-206 study (ClinicalTrials.gov: NCT02140554). The treatment
  process evolved over time, using learnings from outcomes in the initial patients
  to optimize lovo-cel's benefit-risk profile. Following modest expression of HbAT87Q
  in the initial patients (Group A, n = 7), alterations were made to the treatment
  process for patients subsequently enrolled in Group B (n = 2, patients B1 and B2),
  including improvements to cell collection and lovo-cel manufacturing. After 6 months,
  median Group A peripheral blood vector copy number (>=0.08 c/dg) and HbAT87Q levels
  (>=0.46 g/dL) were inadequate for substantial clinical effect but stable and sustained
  over 5.5 years; both markedly improved in Group B (patient B1: >=0.53 c/dg and >=2.69
  g/dL; patient B2: >=2.14 c/dg and >=6.40 g/dL, respectively) and generated improved
  biologic and clinical efficacy in Group B, including higher total hemoglobin and
  decreased hemolysis. The safety of the lovo-cel for SCD treatment regimen largely
  reflected the known side effects of HSPC collection, busulfan conditioning regimen,
  and underlying SCD; acute myeloid leukemia was observed in two patients in Group
  A and deemed unlikely related to insertional oncogenesis. Changes made during development
  of the lovo-cel treatment process were associated with improved outcomes and provide
  lessons for future SCD GT studies."
raw_completion_output: |-
  primary_disease: Sickle Cell Disease (SCD)
  medical_actions: Autologous transplantation of hematopoietic stem and progenitor cells; Improvements to cell collection; Improvements to lovo-cel manufacturing; Busulfan conditioning regimen
  symptoms: Inadequate HbAT87Q levels; Hemolysis
  chemicals: BB305 lentiviral vector; HbAT87Q; Busulfan
  action_annotation_relationships: Autologous transplantation of hematopoietic stem and progenitor cells (with BB305 lentiviral vector) TREATS inadequate HbAT87Q levels IN Sickle Cell Disease (SCD); Improvements to cell collection TREATS inadequate HbAT87Q levels IN Sickle Cell Disease (SCD); Improvements to lovo-cel manufacturing TREATS inadequate HbAT87Q levels IN Sickle Cell Disease (SCD); Busulfan conditioning regimen PREVENTS hemolysis IN Sickle Cell Disease (SCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Busulfan conditioning regimen PREVENTS hemolysis IN Sickle Cell Disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - Autologous transplantation of hematopoietic stem and progenitor cells
    - Improvements to cell collection
    - Improvements to lovo-cel manufacturing
    - Busulfan conditioning regimen
  symptoms:
    - Inadequate HbAT87Q levels
    - Hemolysis
  chemicals:
    - BB305 lentiviral vector
    - HbAT87Q
    - CHEBI:28901
  action_annotation_relationships:
    - subject: <Autologous transplantation of hematopoietic stem and progenitor cells>
      predicate: <TREATS>
      object: <inadequate HbAT87Q levels>
      qualifier: MONDO:0007374
      subject_qualifier: <with BB305 lentiviral vector>
      subject_extension: <BB305 lentiviral vector>
    - subject: Improvements to cell collection
      predicate: TREATS
      object: inadequate HbAT87Q levels
      qualifier: MONDO:0007374
    - subject: Improvements to lovo-cel manufacturing
      predicate: TREATS
      object: inadequate HbAT87Q levels
      qualifier: MONDO:0007374
      subject_extension: lovo-cel
    - subject: MAXO:0000750
      predicate: PREVENTS
      object: hemolysis
      qualifier: MONDO:0007374
      subject_extension: CHEBI:28901
named_entities:
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0000747
    label: Allogeneic hematopoietic stem cell transplantation (HSCT)
  - id: HP:0007760
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:28901
    label: Busulfan
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: HP:0001297
    label: Stroke
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: MONDO:0011382
    label: sickle cell anemia
  - id: MAXO:0000149
    label: allogeneic human leukocyte antigen (HLA)-matched sibling and haploidentical
      hematopoietic cell transplant (HCT)
  - id: CHEBI:17303
    label: morphine
  - id: CHEBI:35482
    label: opioid analgesics
  - id: HP:0012532
    label: chronic pain
  - id: CHEBI:6121
    label: ketamine
  - id: HP:0012531
    label: pain
  - id: MAXO:0000748
    label: fecal microbiota transplantation (FMB)
  - id: CHEBI:26666
    label: SCFA
  - id: CHEBI:17968
    label: butyrate
  - id: CHEBI:31011
    label: valerate
  - id: CHEBI:17272
    label: propionate
  - id: MONDO:0005399
    label: Venous thromboembolism (VTE)
  - id: HP:0002140
    label: Ischemic cerebrovascular accidents
  - id: HP:0002098
    label: respiratory distress
  - id: CHEBI:8735
    label: PAINReportIt(R)
  - id: MAXO:0000066
    label: Oxygen supplementation
  - id: MAXO:0000756
    label: Blood transfusions
  - id: HP:0002094
    label: Dyspnea
  - id: CHEBI:33281
    label: antibiotic
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001395
    label: Liver fibrosis
  - id: MAXO:0000750
    label: conditioning regimen (alemtuzumab, total body irradiation, and sirolimus
      for GVHD prophylaxis)
  - id: CHEBI:9168
    label: sirolimus
  - id: MONDO:0005812
    label: Influenza
  - id: MONDO:0100096
    label: COVID-19
  - id: MONDO:0003847
    label: Genetic diseases
  - id: MONDO:0002492
    label: Acute Kidney Injury (AKI)
  - id: CHEBI:35457
    label: angiotensin-converting enzyme inhibitors
  - id: HP:0001919
    label: AKI
  - id: MONDO:0005300
    label: chronic kidney disease
  - id: HP:0031589
    label: Suicidal ideation
  - id: HP:0000739
    label: anxiety
  - id: MONDO:0005252
    label: heart failure
  - id: MONDO:0005249
    label: pneumonia
  - id: MONDO:0005068
    label: MI
  - id: MONDO:0011751
    label: COPD
  - id: HP:0001907
    label: Thromboembolic events
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001511
    label: Fetal growth restriction
  - id: HP:0001622
    label: Preterm birth
  - id: HP:0003826
    label: Stillbirth
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: CHEBI:18050
    label: l-glutamine
  - id: HP:0008209
    label: Premature ovarian insufficiency
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: CHEBI:17115
    label: Statistical Software Package(s)
  - id: HP:0001903
    label: anemia
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MONDO:0010094
    label: sickle cell trait (SCT)
  - id: HP:0000822
    label: hypertension
  - id: HP:0001626
    label: cardiovascular disease
  - id: HP:0000093
    label: proteinuria
  - id: HP:0000083
    label: kidney failure
  - id: HP:0000112
    label: kidney disease
  - id: HP:0001997
    label: Gout
  - id: HP:0002863
    label: myelodysplastic syndrome
  - id: HP:0003418
    label: Back pain
  - id: HP:0002018
    label: Nausea
  - id: HP:0002019
    label: Constipation
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0100785
    label: Insomnia
  - id: CHEBI:50443
    label: hematopoietic stem cells (HSCs)
  - id: HP:0000789
    label: infertility
  - id: CHEBI:41879
    label: dexamethasone
  - id: CHEBI:64360
    label: Tocilizumab
  - id: MONDO:0011549
    label: Hyperhemolysis syndrome (HHS)
  - id: HP:0001896
    label: Reticulocytopenia
  - id: MAXO:0001017
    label: Vaccination
  - id: CHEBI:66919
    label: Ruxolitinib
  - id: CHEBI:76612
    label: Ibrutinib
  - id: MONDO:0013517
    label: beta-thalassemia (beta-TM)
  - id: MONDO:0005047
    label: Infertility
  - id: CHEBI:46195
    label: Acetaminophen
  - id: CHEBI:41423
    label: Celecoxib
  - id: CHEBI:63629
    label: Tizanidine
  - id: CHEBI:6129
    label: Ketorolac
  - id: MONDO:0005290
    label: Rhabdomyolysis
  - id: MAXO:0001121
    label: Kidney biopsy
  - id: MAXO:0000387
    label: Muscle biopsy
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: MONDO:0005632
    label: Acute chest syndrome
  - id: CHEBI:16480
    label: nitric oxide
  - id: CHEBI:28304
    label: heparin
  - id: MONDO:0013730
    label: Graft versus host disease (GvHD)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: HP:0002615
    label: Hypotension
  - id: HP:0001662
    label: Bradycardia
  - id: CHEBI:119915
    label: Fentanyl
